omega-n-methylarginine has been researched along with atenolol in 6 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (atenolol) | Trials (atenolol) | Recent Studies (post-2010) (atenolol) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 5,473 | 1,950 | 852 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | atenolol (IC50) |
|---|---|---|---|
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.7468 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.23 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.23 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Bowman, AJ; Chen, CP; Ford, GA | 1 |
| Hucks, D; Priest, RM; Ward, JP | 1 |
| Kang, KB; Majewski, H; van der Zypp, A | 1 |
| Lim, PO; MacDonald, TM; Tzemos, N | 1 |
| Avolio, AP; Cockcroft, JR; McEniery, CM; Qasem, A; Schmitt, M; Webb, DJ; Wilkinson, IB | 1 |
2 trial(s) available for omega-n-methylarginine and atenolol
| Article | Year |
|---|---|
Nitric oxide mediated venodilator effects of nebivolol.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Arginine; Atenolol; Benzopyrans; Dinoprost; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Ethanolamines; Hand; Humans; Infusions, Intravenous; Male; Nebivolol; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Vasodilation; Vasodilator Agents; Veins | 1994 |
Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Benzopyrans; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Ethanolamines; Female; Forearm; Humans; Hypertension; Male; Middle Aged; Nebivolol; Nitroprusside; omega-N-Methylarginine; Vasoconstriction; Vasodilation; Vasodilator Agents | 2001 |
4 other study(ies) available for omega-n-methylarginine and atenolol
| Article | Year |
|---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Noradrenaline, beta-adrenoceptor mediated vasorelaxation and nitric oxide in large and small pulmonary arteries of the rat.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Dinoprost; Dose-Response Relationship, Drug; Isoproterenol; Male; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Oxytocics; Propanolamines; Propranolol; Pulmonary Artery; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 1997 |
Age-related involvement of the endothelium in beta-adrenoceptor-mediated relaxation of rat aorta.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aging; Animals; Aorta, Thoracic; Apamin; Atenolol; Charybdotoxin; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Isoproterenol; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Peptides; Phenylephrine; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Vasoconstriction; Vasodilation | 2000 |
Nebivolol increases arterial distensibility in vivo.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzopyrans; Blood Pressure; Butoxamine; Drug Evaluation, Preclinical; Enzyme Inhibitors; Ethanolamines; Hindlimb; Iliac Artery; Infusions, Intra-Arterial; Nebivolol; Nitric Oxide; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Receptors, Adrenergic, beta-2; Sheep; Vascular Resistance | 2004 |